Abstract
Objective: To determine whether metronidazole has an adverse effect on the growth of Lactobacillus.
Methods: Hydrogen peroxide- and bacteriocin-producing strains of Lactobacillus were used as test strains. Concentrations of metronidazole used ranged from 128 to 7000 μg/ml. Susceptibility to metronidazole was conducted by the broth microdilution method recommended by the National Committee for Clinical Laboratory Standards.
Results: Growth of Lactobacillus was partially inhibited at concentrations between 1000 and 4000 μg/ml (p = 0.014). Concentrations ≥ 5000 μg/ml completely inhibited growth of Lactobacillus. Concentrations between 128 and 256 μg/ml stimulated growth of Lactobacillus (p = 0.025 and 0.005, respectively). Concentrations of metronidazole between 64 and 128 μg/ml or ≥ 512 μg/ml did not have an inhibitory or a stimulatory effect on the growth of Lactobacillus compared to the control.
Conclusions: High concentration of metronidazole, i.e. between 1000 and 4000 μg/ml, partially inhibited the growth of Lactobacillus. Concentrations ≥ 5000 μg/ml completely suppressed the growth of Lactobacillus. Concentrations between ≥ 128 and ≤ 256 μg/ml stimulated the growth of Lactobacillus. Further investigation to determine the ideal concentration of metronidazole is needed in order to use the antimicrobial agent effectively in the treatment of bacterial vaginosis.
Full Text
The Full Text of this article is available as a PDF (203.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Agnew K. J., Hillier S. L. The effect of treatment regimens for vaginitis and cervicitis on vaginal colonization by lactobacilli. Sex Transm Dis. 1995 Sep-Oct;22(5):269–273. doi: 10.1097/00007435-199509000-00001. [DOI] [PubMed] [Google Scholar]
- Bayer A. S., Chow A. W., Concepcion N., Guze L. B. Susceptibility of 40 lactobacilli to six antimicrobial agents with broad gram-positive anaerobic spectra. Antimicrob Agents Chemother. 1978 Nov;14(5):720–722. doi: 10.1128/aac.14.5.720. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cunningham F. E., Kraus D. M., Brubaker L., Fischer J. H. Pharmacokinetics of intravaginal metronidazole gel. J Clin Pharmacol. 1994 Nov;34(11):1060–1065. doi: 10.1002/j.1552-4604.1994.tb01981.x. [DOI] [PubMed] [Google Scholar]
- Davis B., Glover D. D., Larsen B. Analysis of metronidazole penetration into vaginal fluid by reversed-phase high-performance liquid chromatography. Am J Obstet Gynecol. 1984 Aug 1;149(7):802–803. doi: 10.1016/0002-9378(84)90130-3. [DOI] [PubMed] [Google Scholar]
- Hillier S. L., Lipinski C., Briselden A. M., Eschenbach D. A. Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis. Obstet Gynecol. 1993 Jun;81(6):963–967. [PubMed] [Google Scholar]
- Livengood C. H., 3rd, McGregor J. A., Soper D. E., Newton E., Thomason J. L. Bacterial vaginosis: efficacy and safety of intravaginal metronidazole treatment. Am J Obstet Gynecol. 1994 Mar;170(3):759–764. doi: 10.1016/s0002-9378(94)70278-0. [DOI] [PubMed] [Google Scholar]
- Livengood C. H., 3rd, Soper D. E., Sheehan K. L., Fenner D. E., Martens M. G., Nelson A. L., Ismail M., Thorp J. M., Lappin M., Long B. J. Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis. Sex Transm Dis. 1999 Mar;26(3):137–142. doi: 10.1097/00007435-199903000-00003. [DOI] [PubMed] [Google Scholar]
- Paavonen J., Mangioni C., Martin M. A., Wajszczuk C. P. Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. Obstet Gynecol. 2000 Aug;96(2):256–260. doi: 10.1016/s0029-7844(00)00902-9. [DOI] [PubMed] [Google Scholar]
- Ralph E. D., Clarke D. A. Inactivation of metronidazole by anaerobic and aerobic bacteria. Antimicrob Agents Chemother. 1978 Sep;14(3):377–383. doi: 10.1128/aac.14.3.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sobel J. D., Schmitt C., Meriwether C. Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. J Infect Dis. 1993 Mar;167(3):783–784. doi: 10.1093/infdis/167.3.783. [DOI] [PubMed] [Google Scholar]
- Ugwumadu A. H., Hay P. Bacterial vaginosis: sequelae and management. Curr Opin Infect Dis. 1999 Feb;12(1):53–59. doi: 10.1097/00001432-199902000-00010. [DOI] [PubMed] [Google Scholar]